53 related articles for article (PubMed ID: 30765126)
1. Compared staining of the phospholipase A2 receptor in the glomeruli of Chinese adults and children with idiopathic membranous nephropathy.
Zhang D; Wu Y; Zhang C; Zhang W; Zou J; Jiang G
Pathol Res Pract; 2019 May; 215(5):952-956. PubMed ID: 30765126
[TBL] [Abstract][Full Text] [Related]
2. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN.
Ren S; Wu C; Zhang Y; Wang AY; Li G; Wang L; Hong D
Ren Fail; 2018 Nov; 40(1):306-313. PubMed ID: 29623759
[TBL] [Abstract][Full Text] [Related]
3. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L
Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis.
Dai H; Zhang H; He Y
Sci Rep; 2015 Mar; 5():8803. PubMed ID: 25740009
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of serum anti-PLA2R levels and glomerular PLA2R deposits in primary membranous nephropathy.
Chaitanya Gunda K; Mathew GG; Balasubramanian S; Sunil Kumar KS
G Ital Nefrol; 2024 Apr; 41(2):. PubMed ID: 38695230
[No Abstract] [Full Text] [Related]
6. Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.
Kao L; Lam V; Waldman M; Glassock RJ; Zhu Q
J Am Soc Nephrol; 2015 Feb; 26(2):291-301. PubMed ID: 25205735
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase A2 Receptor Antibodies and Clinical Prognosis in Patients with Idiopathic Membranous Nephropathy: An Updated Systematic Review and Meta-Analysis.
Zhang J; Fan Z; Wang P; Zhang AH
Kidney Blood Press Res; 2023; 48(1):102-113. PubMed ID: 36720217
[TBL] [Abstract][Full Text] [Related]
8. The diversity of peripheral blood T cells and myeloid-derived suppressor cells in patients with idiopathic membranous nephropathy.
Shi X; Zhang M; Wang G; Chen G; Hu R; Lee X; Li X
Clin Nephrol; 2024 Jun; 101(6):287-297. PubMed ID: 38511675
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic characteristics of idiopathic membranous nephropathy with dual antigen positivity.
Yang L; Wang G; Ye N; Xu X; Cheng W; Sun L; Dong H; Kong L; Zhao X; Geng Y; Cheng H
Front Immunol; 2023; 14():1297107. PubMed ID: 38250076
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of phospholipase A2 receptor autoantibodies on spontaneous remission for patients with idiopathic membranous nephropathy: A meta-analysis.
Wu W; Shang J; Tao C; Wang S; Hu X; Zhang S; Zhao Z
Medicine (Baltimore); 2018 Jun; 97(23):e11018. PubMed ID: 29879066
[TBL] [Abstract][Full Text] [Related]
11. Serum phospholipase A2 receptor antibody is associated with thrombogenesis in patients with idiopathic membranous nephropathy.
Zhang Q; Liu G
Kidney Blood Press Res; 2024 Jun; ():. PubMed ID: 38865986
[TBL] [Abstract][Full Text] [Related]
12. How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy.
Caza TN; Al-Rabadi LF; Beck LH
Front Immunol; 2021; 12():800242. PubMed ID: 34899763
[TBL] [Abstract][Full Text] [Related]
13. Obinutuzumab in the treatment of PLA2R-positive membranous glomerulonephritis resistant to treatment.
de la Prada Álvarez FJ; Cintra Cabrera M; Almenara Tejederas M; Burgos Martin J; Alonso García F; Salgueira Lazo M
Nefrologia (Engl Ed); 2024; 44(2):306-307. PubMed ID: 38631964
[No Abstract] [Full Text] [Related]
14. Analysis of Clinicopathological Characteristics of Malignancy Patients with Membranous Nephropathy and Literature Review.
Wang G; Hu X; Ye N; Xu X; Guo W; Sun L; Dong H; Zhao X; Cheng H
Cancer Manag Res; 2024; 16():677-689. PubMed ID: 38919875
[TBL] [Abstract][Full Text] [Related]
15. Oral bacteriome and mycobiome of patients with idiopathic membranous nephropathy with different tongue coatings treated with a Chinese herbal formula.
Wang XH; Yang YN; Li YH; Cheng JL; Yan L; Liang Y; Zeng Q; Zhan T; Wang DW; Yu RH; Wu CM
J Ethnopharmacol; 2024 Sep; 331():118233. PubMed ID: 38685365
[TBL] [Abstract][Full Text] [Related]
16. Primary membranous nephropathy in children and adolescents: a single-centre report from South Asia.
Ramachandran R; Nayak S; Kumar V; Kumar A; Agrawal N; Bansal R; Tiewsoh K; Nada R; Rathi M; Kohli HS
Pediatr Nephrol; 2021 May; 36(5):1217-1226. PubMed ID: 33108509
[TBL] [Abstract][Full Text] [Related]
17. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery.
van de Logt AE; Fresquet M; Wetzels JF; Brenchley P
Kidney Int; 2019 Dec; 96(6):1292-1302. PubMed ID: 31611068
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients.
Sethi S; Debiec H; Madden B; Vivarelli M; Charlesworth MC; Ravindran A; Gross L; Ulinski T; Buob D; Tran CL; Emma F; Diomedi-Camassei F; Fervenza FC; Ronco P
Kidney Int; 2020 Nov; 98(5):1253-1264. PubMed ID: 32534052
[TBL] [Abstract][Full Text] [Related]
19. The Clinical Profile and Long-Term Outcome of Children with Membranous Nephropathy, and the Evaluation of Anti-Phospholipase A2 Receptor Antibody Immunohistochemistry in Kidney Biopsy.
Deepthi RV; George S; Mathew G; Roy S; Bindra M; Rebekah G; Agarwal I
Indian J Nephrol; 2023; 33(6):432-439. PubMed ID: 38174298
[TBL] [Abstract][Full Text] [Related]
20. How to Choose the Right Treatment for Membranous Nephropathy.
Peritore L; Labbozzetta V; Maressa V; Casuscelli C; Conti G; Gembillo G; Santoro D
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
